Pulse.

a daily field guide to health research that matters

◆ Console

‹ Tue · 7 Jul 2026
Novel or significantly improved treatment

Locoregional recurrence patterns and prognostic outcomes in early-stage natural killer/T-cell lymphoma treated with sandwich chemoradiotherapy: A post hoc analysis of a randomized controlled trial.

BACKGROUND AND PURPOSE: This study aimed to evaluate the locoregional control in early-stage natural killer/T-cell lymphoma (NKTCL) patients treated with sandwich chemoradiotherapy. CONCLUSION: Asparaginase-based sandwich chemoradiotherapy shows favorable efficacy in early-stage NKTCL, with distinct locoregional recurrence patterns.

BACKGROUND AND PURPOSE: This study aimed to evaluate the locoregional control in early-stage natural killer/T-cell lymphoma (NKTCL) patients treated with sandwich chemoradiotherapy. CONCLUSION: Asparaginase-based sandwich chemoradiotherapy shows favorable efficacy in early-stage NKTCL, with distinct locoregional recurrence patterns.

What the study was

Study design
Randomized controlled trial
Category
Treatment Innovation
Maturity
Potentially Practice-Changing
Journal
Practical radiation oncology

Why it surfaced

High-priority Hematologic malignancies study: novel treatment potential warrants immediate pipeline escalation.

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.